Collegium Pharmaceutical is a diversified specialty pharmaceutical company dedicated to improving the lives of individuals affected by serious medical conditions. The company develops and markets a range of differentiated medications aimed at addressing severe and persistent pain, as well as attention-deficit/hyperactivity disorder (ADHD). Collegium emphasizes the importance of responsible pain management and strives for meaningful engagement with healthcare professionals to ensure effective treatment options are accessible. The organization's core values include collaboration, innovation, and a commitment to quality, fostering an environment where employees can excel and contribute to the company’s mission of enhancing patient outcomes. With a focus on compliance and ethical practices, Collegium is positioned as a leader in the specialty pharmaceutical space.